«Islet transplants have been used to successfully treat patients with unstable, high - risk type 1 diabetes, but the procedure has limitations, including a very limited supply of donor organs and challenges in obtaining reliable and consistent islet preparations,» said trial investigator James Shapiro, MD, PhD, FRCSC, Director of
the Clinical Islet Transplant Program, University of Alberta.
Clinical Islet Transplant Program 2000 College Plaza 8215 - 112th Street Edmonton, Alberta, Canada T6G 2C8 780-407-1501 (phone) 780-407-3850 (fax) Email:
[email protected]
Dr. James Shapiro and
the Clinical Islet Transplant Program are currently investigating the possibility of living donor islet transplantation, but do not have an active program set up as yet in Edmonton.
The following individuals are closely involved with
the Clinical Islet Transplant Program in Edmonton:
Dr Andrew Malcolm Director of Research Operations
Clinical Islet Transplant Program 2000 College Plaza 8215 - 112th Street Edmonton, Alberta, Canada T6G 2C8
[email protected]
«The loss of insulin - producing beta cells leads to type 1 diabetes, making it an ideal target for cell replacement therapy,» said James Shapiro, MD, PhD, FRCSC, Director of
the Clinical Islet Transplant Program, University of Alberta.
Not exact matches
Although cord blood stem cell
transplant is becoming increasingly promising, the
Clinical Islet Program is not currently involved with cord blood as a treatment for diabetes.
June 6, 2000 Immune Tolerance Network to fund expanded
clinical trial of Edmonton
islet transplant technique The Immune Tolerance Network will fund a multi-center
clinical trial of
islet transplantation to study the technique that reversed diabetes in all eight patients treated.
The Emory
Transplant Center has conducted
clinical trials since 2003
transplanting human pancreatic
islet cells into patients with Type I diabetes.
The trial, a first in
islet transplantation, is slated to begin in the fall of this year and will involve approximately 32 new
transplants at up to eight
clinical centers across North America and Europe.